The maximum dose of Mounjaro: reaching 15mg safely

Why 15mg is the ceiling, not the default

Eli Lilly designed the Mounjaro dose schedule with tolerability as its first priority. Treatment begins at 2.5mg, a strength chosen specifically because it lets your body adjust to the dual GIP and GLP-1 receptor activation before any meaningful therapeutic effect kicks in. The increments that follow (5mg, 7.5mg, 10mg, 12.5mg, then 15mg) are spaced at a minimum of four weeks each, giving your system time to settle at each level before the prescriber considers moving up.

The 15mg maximum dose is the strength studied most intensively in the SURMOUNT-1 trial, where participants at that level achieved an average body-weight reduction of around 20–21% over 72 weeks. Those figures, cited in the SURMOUNT-1 paper published in the New England Journal of Medicine, are often quoted as the headline result for tirzepatide, but they represent the highest dose, sustained to the end of a long clinical trial. Real-world experience varies.

The prescriber's job is not to push everyone to 15mg. If 10mg is producing consistent weight loss and you're tolerating it well, there may be no clinical reason to go further. The maximum dose exists because some people need it; it isn't a target everyone is expected to reach. The full dose schedule sets out what each step involves.

The clinical factors that influence whether you escalate

Several things shape whether a prescriber will move your dose upward. The most important is your response at the current level: if weight loss has stalled for several weeks, that's a signal worth discussing. The second is side effects. Nausea, loose stools, reflux and reduced appetite are common after a dose increase, typically settling within a couple of weeks, but if GI symptoms are still disruptive by the time a review falls due, your prescriber may recommend holding at the current dose rather than escalating.

There's also a practical piece worth knowing. Each Mounjaro KwikPen contains four weekly doses of a single strength, so a quick way to stay on top of your supply is to check your pen after each injection and note which injection number you're on. That one-minute habit means you're never caught short before your next delivery. Checking how many doses remain in a pen is simpler than most people expect.

At nume, sorry. At our pharmacy, every dose increase requires a clinical re-review. A named, GPhC-registered Independent Prescriber assesses your progress before any higher-strength pen is dispensed. That review considers your weight trajectory, any reported side effects and, where relevant, your broader health. It is not automatic.

What NICE guidance says about dose response and the maximum

NICE's appraisal of tirzepatide (TA1026) includes a specific consideration for people who are on the highest tolerated dose and have not achieved at least 5% weight loss after six months. In that scenario, NICE recommends that continuing treatment is reviewed rather than assumed. This matters because it means the decision to stay at (or reach) the maximum dose should be framed around your actual response, not just the number on the pen.

NICE's guidance on tirzepatide (TA1026) outlines the full eligibility and treatment-review framework. The cost of Mounjaro in the UK is worth factoring in at this stage too, since higher doses carry a higher per-pen price under the post-September 2025 Lilly pricing structure; reported market prices at the top of the schedule now range from around £330 to £375 per four-week pen depending on the provider.

The key practical point: if you're approaching the 15mg ceiling, your prescriber should be actively reviewing your trajectory, not simply renewing the prescription. That's built into how a well-run clinical service operates. Spacing between doses must remain consistent at seven days regardless of which strength you're on.

Reaching the maximum dose: what this means for your treatment plan

People who do reach 15mg typically stay there for as long as the treatment continues to produce benefit and remains well tolerated. At that point the conversation with your prescriber shifts from titration to maintenance: monitoring your weight, managing any ongoing side effects and reviewing whether continuing at the maximum is still clinically appropriate.

It's also worth knowing that 15mg is the maximum dose of tirzepatide under the current UK licence regardless of body weight, BMI or how long you've been on treatment. There is no provision for a higher dose, and no clinical basis for anyone suggesting otherwise. The maximum dosage of Mounjaro in the UK is fixed by the regulator.

If you're weighing up whether Mounjaro is right for your situation, or wondering what the titration journey looks like from the beginning, starting with a free consultation is the clearest way to get an honest clinical picture.